| NWRD06 DNA Plasmid for HCC After Radical Resection (NCT06088459) | Newish Technology (Beijing) Co., Ltd. | 2023-11-01 |
| Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma (NCT06132438) | Charlotte Lemech | 2023-11-01 |
| Comparison Between the Effect of Aloe Vera and Benzydamine Hydrochloride Mouth Gel on Prevention of Pain and Progression of Radiation-induced Oral Mucositis (NCT06862817) | Minia University | 2023-11-01 |
| Keratinized Tissue Augmentation Using Porcine Collagen Matrix (Mucoderm®) Around Dental Implant (NCT06753084) | ahmed amer | 2023-11-01 |
| A Clinical Trial of TQB3454 Tablets in Healthy Adult Subjects (NCT06139367) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2023-11-01 |
| Umbilical Cord Mesenchymal Stem Cell for Aging-related Low-grade Inflammation (NCT06448052) | Nguyen Ton Ngoc Huynh | 2023-11-01 |
| Halting Ornithine Transcarbamylase Deficiency With Recombinant AAV in ChildrEn (NCT05092685) | University College, London | 2023-11-01 |
| Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis (NCT06047379) | Neonc Technologies, Inc. | 2023-11-01 |
| Local Delivery of Silk Fibroin and Chlorhexidine (NCT06050863) | Krishnadevaraya College of Dental Sciences & Hospital | 2023-11-01 |
| SCORE Emerging Adult Cannabis Use & Stress (NCT05885542) | Medical University of South Carolina | 2023-11-01 |
| Safety and Tolerability of OCU-10-C-110 for Injection in Subjects With Neovascular Age-related Macular Degeneration (NCT05904691) | Ocugenix Corporation | 2023-11-01 |
| A Study to Evaluate Vonoprazan in Children Who Have Symptomatic Gastroesophageal Reflux Disease (NCT06106022) | Phathom Pharmaceuticals, Inc. | 2023-11-01 |
| An Open-label Study of the Safety and Pharmacokinetics of the TGKP (NCT06127381) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2023-11-01 |
| An Exploratory Clinical Study to Investigate the Effect of autoSTEM-OA and alloSTEM-OA in Participants With Knee Osteoarthritis (NCT05789719) | StemMedical A/S | 2023-11-01 |
| Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer (NCT06121570) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2023-11-01 |
| High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Sitagliptin for the Prevention of GVHD (NCT05895201) | Indiana University | 2023-11-01 |
| Expanding Use of CGM in Critical Care: Impact on Nurse Work Patterns and Patient Outcomes (NCT05571397) | Ohio State University | 2023-11-01 |
| Clinical Study on the Treatment of Advanced Recurrent Tumors With Anticancer Mouse Characteristic Human Neutrophils (NCT06240767) | Wuxi People's Hospital | 2023-11-01 |
| Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1) (NCT05862012) | Ichnos Sciences SA | 2023-11-01 |
| Universal CAR-T Cells Targeting Multiple Myeloma (NCT06006741) | Shenzhen Geno-Immune Medical Institute | 2023-10-31 |
| A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors (NCT05970497) | Krystal Biotech, Inc. | 2023-10-31 |
| Safety, Tolerability, Pharmacokinetics, Radiation Dosimetry, and PET Imaging Properties of 89Zr-labeled hNd2 (NMK89) in Patients With Pancreatic Cancer (NCT06129422) | Nihon Medi-Physics Co., Ltd. | 2023-10-31 |
| EffIcacy Between Arthrocentesis With High Versus Low Molecular Weight Hyaluronic Acid in Treatment of TMJ Disorders (NCT06694532) | Basel khaled mohamed | 2023-10-31 |
| Study of TRX-920 for Patients With Advanced Solid Tumors (NCT06143774) | TaiRx, Inc. | 2023-10-31 |
| Safety and Efficacy Trial of HG004 for Leber Congenital Amaurosis Related to Rpe65 Gene Mutations (STAR) (NCT05906953) | HuidaGene Therapeutics Co., Ltd. | 2023-10-31 |
| Effect of Tigulixostat on the Pharmacokinetics of Theophylline (NCT06189404) | LG Chem | 2023-10-31 |
| A Study to Evaluate the Drug Levels, Metabolism, and Removal of BMS-986322 in Healthy Adult Male Participants (NCT06088264) | Bristol-Myers Squibb | 2023-10-31 |
| Neoadjuvant Camrelizumab With Dalpiciclib for Resectable Head and Neck Squamous Cell Carcinomas (NCT06109207) | West China Hospital | 2023-10-31 |
| A Pharmacokinetic Study of Lanifibranor in Healthy Adult Chinese Subjects (NCT06126562) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2023-10-31 |
| A First Time in Human Study to Evaluate the Safety and Tolerability of GSK4381406 in Healthy Participants (NCT05999708) | GlaxoSmithKline | 2023-10-31 |
| A Clinical Trail to Compare Pharmacokinetics of Two PEG-rhGH Injections With Different Preparations (NCT06135168) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2023-10-31 |
| Study of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and Adolescents (NCT06128733) | Sanofi Pasteur, a Sanofi Company | 2023-10-31 |
| Universal 4SCAR7U Targeting CD7-positive Malignancies (NCT05995028) | Shenzhen Geno-Immune Medical Institute | 2023-10-31 |
| First-in-Human Trial in Healthy Adult Volunteers to Evaluate Safety, Tolerability and PK of LAPIX Study Drug; LPX-TI641 (NCT05853835) | LAPIX Therapeutics Inc. | 2023-10-30 |
| A Prospective Clinical Study of Bridging alloHSCT After Treatment With Obinutuzumab in Combination With Chidamide and Venetoclax in RR Ph-ALL and B-cell Lymphoma Patients (NCT06087419) | Institute of Hematology & Blood Diseases Hospital, China | 2023-10-30 |
| Homologous Re-infection With Dengue 1 or Dengue 3 (NCT05967455) | State University of New York - Upstate Medical University | 2023-10-30 |
| A Study of SI-B001+SI-B003± Chemotherapy in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer (NCT05949606) | Sichuan Baili Pharmaceutical Co., Ltd. | 2023-10-30 |
| A Study to Learn How the Body Processes the Study Medicine Called PF-07923568 in People With Loss of Kidney Function (NCT06037031) | Pfizer | 2023-10-30 |
| SC0191 Plus Chemotherapy in Advanced Ovarian Canceradvanced Ovarian Cancer (NCT06055348) | Biocity Biopharmaceutics Co., Ltd. | 2023-10-30 |
| Pharmacokinetics and Safety Study of Levornidazole Disodium Phosphate for Injection in Subjects With Renal Impairment and Normal Renal Impairment (NCT07033182) | Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd | 2023-10-30 |
| Safety and Tolerance Study of IBI355 in Health Volunteers (NCT06110338) | Innovent Biologics (Suzhou) Co. Ltd. | 2023-10-30 |
| A TQT Study to Evaluate the Electrocardiographic Effects of Carbidopa in Healthy Subjects (NCT06161220) | Impax Laboratories, LLC | 2023-10-30 |
| IN10018 Combination Therapy in Treatment-naïve ES-SCLC (NCT06030258) | InxMed (Shanghai) Co., Ltd. | 2023-10-30 |
| A Study of PM1021 (Anti-TIGIT) With or Without PM8001 (Anti-PD-L1/TGF-β) in Patients With Advanced Solid Tumours (NCT05537051) | Biotheus Inc. | 2023-10-30 |
| Study of ALE.C04 in Patients With Head and Neck Cancer (NCT06054477) | Alentis Therapeutics AG | 2023-10-30 |
| A Study of the Effects of Itraconazole on the Plasma Levels of Nemtabrutinib (MK-1026-013) (NCT06688045) | Merck Sharp & Dohme LLC | 2023-10-30 |
| Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases (NCT06316076) | RenJi Hospital | 2023-10-30 |
| Evaluation of the Role of Acetyl Cysteine in Ventilator Associated Pneumonia by Carbapenem Resistance Klebsiella (NCT07097727) | Tanta University | 2023-10-30 |
| PK and PD Study of NPI-001 and Cysteamine Bitartrate (NCT05994534) | Nacuity Pharmaceuticals, Inc. | 2023-10-29 |
| XS005 Injection Combined With Stupp Regimen for Adjuvant Chemotherapy in Subjects With Primary Glioblastoma(GBM) (NCT06147505) | Dushu Lake Hospital Affiliated to Soochow University | 2023-10-29 |
| A Study in Healthy Men to Test How Well Different Doses of BI 3802876 Are Tolerated (NCT06081530) | Boehringer Ingelheim | 2023-10-27 |
| A Study to Evaluate Vaxart's Oral Bivalent GI.1/GII.4 Norovirus Vaccine in Healthy Lactating Females and Their Nursing Infants (NCT07254728) | Vaxart | 2023-10-27 |
| Study of ZG006 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma (NCT05978284) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2023-10-27 |
| Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma (NCT05743595) | Washington University School of Medicine | 2023-10-27 |
| Clinical Trial to Demonstrate the Safety and Efficacy of DUOFAG® (NCT06319235) | MB PHARMA s.r.o. | 2023-10-27 |
| Drug-drug Interactions Between DWC202313 and DWC202314 in Healthy Subjects (NCT06119958) | Daewoong Pharmaceutical Co. LTD. | 2023-10-27 |
| A Study to Learn How Different Amounts of the Study Medicine Called PF-07976016 Are Tolerated and Act in The Body in Healthy Adults (NCT06106009) | Pfizer | 2023-10-27 |
| A Drug-Drug Interaction Study of LY3537982 on Midazolam, Digoxin, and Rosuvastatin in Healthy Participants (NCT06111521) | Eli Lilly and Company | 2023-10-27 |
| Study of the Safety, Tolerability, Pharmacokinetics and Food Effects of VV119 Capsules in Chinese Healthy Volunteers (NCT06105151) | Vigonvita Life Sciences | 2023-10-27 |
| OriCAR-017 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of R/RMM (NCT06182696) | OriCell Therapeutics Co., Ltd. | 2023-10-26 |
| A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours (NCT06725758) | Orion Corporation, Orion Pharma | 2023-10-26 |
| A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers (NCT05873686) | Nuvectis Pharma, Inc. | 2023-10-26 |
| An Open-Label, Multicenter, Phase I Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of YY201 in Patients With Advanced Solid Tumors and Hematological Malignancies (NCT06225856) | Shanghai Yuyao Biotech Co., Ltd. | 2023-10-26 |
| A Phase 1 Clinical Trial DHP2306R1 and DHP2306R2 in Healthy Adult Volunteers (NCT06395155) | Daehwa Pharmaceutical Co., Ltd. | 2023-10-26 |
| Sacituzumab Tirumotecan (MK-2870) as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-2870-008) (NCT06049212) | Merck Sharp & Dohme LLC | 2023-10-26 |
| A Phase 1 Study of BB3008 in Participants With Advanced Solid Tumors (NCT06143007) | Broadenbio Ltd., Co. | 2023-10-26 |
| CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma (NCT06026319) | Marcela V. Maus, M.D.,Ph.D. | 2023-10-26 |
| Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury (NCT06103201) | University of Maryland, Baltimore | 2023-10-26 |
| Intensive Speech Motor Chaining Treatment for Residual Speech Sound Disorders (NCT05929859) | Syracuse University | 2023-10-26 |
| A Phase Ib Trial of Azacitidine, Venetoclax and Allogeneic NK Cells for Acute Myeloid Leukemia (ADVENT-AML) (NCT05834244) | M.D. Anderson Cancer Center | 2023-10-26 |
| A Single-And Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of WD-890 Tablets in Healthy Chinese Subjects (NCT06506591) | Zhejiang Wenda Pharma Technology LTD. | 2023-10-26 |
| Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer (NCT06080061) | Stanford University | 2023-10-25 |
| Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Recifercept in Healthy Chinese Participants (NCT05061277) | Pfizer | 2023-10-25 |
| Safety and Efficacy of Oral Administration of the Phage Cocktail, VRELysin™, In Healthy and VRE-Colonized Subjects (NCT05715619) | Intralytix, Inc. | 2023-10-25 |
| Phase I Clinical Study of SHR-5495 in the Treatment of Patients With Advanced Malignant Tumors (NCT06059508) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2023-10-25 |
| Safety and Efficacy of OBX-115 in Advanced Solid Tumors (NCT06060613) | Obsidian Therapeutics, Inc. | 2023-10-25 |
| IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers (NCT06119685) | Indapta Therapeutics, INC. | 2023-10-25 |
| A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML) (NCT05756777) | Memorial Sloan Kettering Cancer Center | 2023-10-25 |
| Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent (NCT06075849) | Panolos Bioscience | 2023-10-25 |
| Feasibility and Safety Study of Parent-to-Child Nasal Microbiota Transplant (NCT05695196) | Johns Hopkins University | 2023-10-25 |
| A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of AZD7503 in Japanese Healthy Participants. (NCT06093542) | AstraZeneca | 2023-10-25 |
| A Clinical Trial to Assess the Safety of SOR102 in Healthy Participants and Patients With Ulcerative Colitis (NCT06080048) | Sorriso Pharmaceuticals, Inc. | 2023-10-24 |
| A Study of CNA3103 (LGR5-targeted, Autologous CAR-T Cells) Administered to Subjects With Metastatic Colorectal Cancer (NCT05759728) | Carina Biotech Limited | 2023-10-24 |
| Study of Inhaled DMC-IH1 and Intramuscular (EpiPen®) Epinephrine in Healthy Male and Female Participants. (NCT06013150) | De Motu Cordis | 2023-10-24 |
| The Effect of Food and Water Volume in Healthy Adult Participants Administered Enlicitide Decanoate (MK-0616) (MK-0616-022) (NCT06658652) | Merck Sharp & Dohme LLC | 2023-10-24 |
| Phase I Study of BL0020, a Novel Anti-tumor Drug, in Adult Subjects With Advanced Solid Tumors (NCT05886868) | Shanghai Best-Link Bioscience, LLC | 2023-10-24 |
| Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas (NCT06156410) | Children's Hospital of Philadelphia | 2023-10-24 |
| Clofarabine Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (NCT07034053) | Ekaterina Laukhtina | 2023-10-24 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Anticancer Activity of GSK4524101 Alone or With Niraparib in Participants With Solid Tumors (NCT06077877) | GlaxoSmithKline | 2023-10-24 |
| High-Dose Ambroxol in GBA1-Related Parkinson (NCT06193421) | Agyany Pharma LTD | 2023-10-24 |
| Dose Escalation of BCX10013 in Participants with Paroxysmal Nocturnal Hemoglobinuria (PNH) (NCT06100900) | BioCryst Pharmaceuticals | 2023-10-24 |
| Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA) (NCT06066424) | M.D. Anderson Cancer Center | 2023-10-24 |
| Dose-Escalation, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GB-6002 Local Infiltration in Healthy Male Adults (NCT06095973) | G2GBio, Inc. | 2023-10-24 |
| Does Serotonin System Stimulation Increase Pro-social Behavior? - A Comparative Pharmacological Neuroscientific Study in Healthy Humans (NCT06081179) | University of Zurich | 2023-10-24 |
| Pan-RAS Inhibitor YL-17231 in Patients With Advanced Solid Tumors Harboring Mutations in KRAS, HRAS, or NRAS (NCT06096974) | Shanghai YingLi Pharmaceutical Co. Ltd. | 2023-10-24 |
| A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents (NCT06090266) | OncoResponse, Inc. | 2023-10-24 |
| Post-Transplant Cyclophosphamide in Patients Aged >/= 65 Years Undergoing Haploidentical Transplant (NCT05849207) | Ronald Paquette | 2023-10-24 |
| A Study of ASKG712 in Patients With Diabetic Macular Edema (NCT05940428) | Visara, Inc. | 2023-10-23 |
| Ascorbate With Durvalumab in Non-Small Cell Lung Cancer (NSCLC) (NCT06083454) | William Zeitler | 2023-10-23 |
| A Study of [14C]-LOXO-783 in Healthy Adult Participants (NCT06102512) | Eli Lilly and Company | 2023-10-23 |